SCHEMBL4032019

SCHEMBL4032019

CC(C)C(O)(c1ccc2cc(C#N)ccc2c1)c1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cn1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACSS2 Q9NR19 1/20 0.38
CYP3A4 P08684 9/20 0.36
F2 P00734 1/20 0.36
PLG P00747 1/20 0.36
PLAU P00749 1/20 0.36
KLKB1 P03952 1/20 0.36
PRSS1 P07477 1/20 0.36
CYP17A1 P05093 6/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
MEN1 O00255 1/20 0.34
SIRT2 Q8IXJ6 2/20 0.34
FNTA P49354 1/20 0.33
FNTB P49356 1/20 0.33
RORC P51449 1/20 0.33
ALOX5 P09917 1/20 0.32
PTPN1 P18031 2/20 0.32
PTPN2 P17706 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5750119 0.90 CYP3A4 (0.36) CYP3A4CYP17A1CYP2C9CYP2C19SIRT2
SCHEMBL4027429 0.85 ACSS2 (0.36) ACSS2F2PLGPLAUKLKB1
SCHEMBL1414974 0.85 CYP3A4 (0.39) CYP3A4CYP17A1CYP2C9CYP2C19SIRT2
SCHEMBL5753019 0.85 CYP3A4 (0.39) ACSS2CYP3A4CYP17A1CYP2C9CYP2C19
SCHEMBL5689382 0.85 CYP17A1 (0.43) ACSS2CYP3A4CYP17A1MEN1FNTA
SCHEMBL5682244 0.84 CYP3A4 (0.38) ACSS2CYP3A4CYP17A1CYP2C9CYP2C19
SCHEMBL4028694 0.84 CYP3A4 (0.38) CYP3A4CYP17A1CYP2C9CYP2C19SIRT2
SCHEMBL5753021 0.84 CYP3A4 (0.38) CYP3A4CYP17A1CYP2C9CYP2C19SIRT2
SCHEMBL4025996 0.84 CYP3A4 (0.41) CYP3A4CYP17A1CYP2C9CYP2C19SIRT2
SCHEMBL7817124 0.84 CYP3A4 (0.36) CYP3A4CYP17A1CYP2C9CYP2C19SIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1222174-B1 IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE TAKEDA PHARMACEUTICAL (JP) 2009-05-27 EP disclosed
US-6649643-B1 Antitumor, anticarcinogenic, and antimetastasis agents; benign prostatic hyperplasia, alopecia, endometriosis, uterine myoma, hirsutism, virilism, precocious puberty, mastopathy, and polycystic overay syndrome treatment TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-11-18 US disclosed
EP-1222174-A1 IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE Takeda Chemical Industries, Ltd. (JP) 2002-07-17 EP disclosed
WO-2001030762-A1 IMIDAZOL-4-YLMETHANOLS USE AS INHIBITORS OF STEROID C17-20 LYASE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-03 WO disclosed